FDA Approves Journavx Drug to Treat Pain Without Addiction Risk
Revolutionary New Nonaddictive Pain Medication Approved by FDA The FDA has approved a groundbreaking new medication, suzetrigine (sold as Journavx), created by Vertex Pharmaceuticals, marking a significant advancement in pain management. Unlike traditional opioid painkillers, suzetrigine is designed to alleviate pain without the risk of addiction, operating exclusively outside the brain to block pain signals. … Read more
